Northwest & Ethical Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-800
Closed -$77.6K 372
2018
Q3
$77.6K Sell
800
-400
-33% -$38.8K ﹤0.01% 340
2018
Q2
$113K Hold
1,200
0.01% 347
2018
Q1
$97.3K Buy
1,200
+400
+50% +$32.4K 0.01% 343
2017
Q4
$71.3K Sell
800
-200
-20% -$17.8K ﹤0.01% 344
2017
Q3
$93.1K Buy
1,000
+400
+67% +$37.2K 0.01% 345
2017
Q2
$72.7K Buy
+600
New +$72.7K ﹤0.01% 357